NTC
BIIB icon

NF Trinity Capital’s Biogen BIIB Stock Holding History

NF Trinity Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-24,000
Closed -$6.97M – 59
2018
Q2 		$6.97M Hold
24,000
– – 0.95% 27
2018
Q1 		$6.57M Hold
24,000
– – 0.9% 27
2017
Q4 		$7.65M Hold
24,000
– – 0.99% 26
2017
Q3 		$7.51M Hold
24,000
– – 1.07% 26
2017
Q2 		$6.51M Hold
24,000
– – 0.92% 26
2017
Q1 		$6.56M Hold
24,000
– – 0.89% 25
2016
Q4 		$6.81M Sell
24,000
-7,200
-23% -$2.13M 0.96% 24
2016
Q3 		$9.77M Sell
31,200
-10,000
-24% -$2.96M 1.09% 24
2016
Q2 		$9.96M Hold
41,200
– – 1.09% 26
2016
Q1 		$10.7M Hold
41,200
– – 1.3% 22
2015
Q4 		$12.6M Buy
+41,200
New +$11.8M 1.43% 21

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

NF Trinity Capital's BIIB Position: Q3 2018 in Review

NF Trinity Capital sold out of Biogen (BIIB) in Q3 2018, closing a stake of 24,000 shares — an estimated $6.97M sold.

NF Trinity Capital first reported a position in BIIB in Q4 2015 and held it in 11 quarters. The position peaked at $12.6M in Q4 2015. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • NF Trinity Capital reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • NF Trinity Capital sold 24,000 Biogen shares in Q3 2018, an estimated $6.97M.
  • NF Trinity Capital first reported a position in Biogen in Q4 2015 and held it in 11 quarters.
  • NF Trinity Capital's Biogen position peaked at $12.6M in Q4 2015.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on NF Trinity Capital's 13F filing for Q3 2018, filed 8 Nov 2018.